文献速递脊柱关节炎

亚洲与非亚洲地区非放射学轴性脊柱关节炎临床特征对比:ASAS-COMOSPA研究

Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study.
PubMed 文献 · RMD Open · 2021-01-01

基于ASAS-COMOSPA横断面数据库,比较亚洲与非亚洲地区非放射学轴性脊柱关节炎(nr-axSpA)的临床特征,并在亚洲内部比较放射学轴性脊柱关节炎(r-axSpA)与nr-axSpA。亚洲axSpA患者中nr-axSpA占14.4%,低于非亚洲国家的24.3%;亚洲nr-axSpA以男性为主、起病和诊断年龄更轻、诊断延迟更短、HLA-B27阳性率更高、外周表现更少,疾病活动度和MRI骶髂关节炎更轻,NSAID应答率更高,MTX和bDMARD使用更少。亚洲内部r-axSpA较nr-axSpA疾病活动度和结构损伤更高。

要点

  • 亚洲axSpA中nr-axSpA占比14.4%,低于非亚洲国家的24.3%。
  • 亚洲nr-axSpA男性占75.9%、HLA-B27阳性率90.6%,均高于非亚洲nr-axSpA。
  • 亚洲nr-axSpA疾病活动度和MRI骶髂关节炎更轻,NSAID应答率更高。

核心结论

  • 亚洲axSpA患者中nr-axSpA频率低于非亚洲地区,临床特征存在地区差异。
  • 亚洲内部r-axSpA较nr-axSpA疾病活动度和结构损伤更高,其他特征无差异。

研究设计与样本

  • 基于ASAS-COMOSPA数据库的横断面研究,共纳入3984例SpA患者,其中1094例来自亚洲国家。
  • 按地区分组比较亚洲与非亚洲nr-axSpA,并在亚洲内部比较nr-axSpA与r-axSpA。

主要发现

  • 亚洲780例axSpA中112例(14.4%)为nr-axSpA,非亚洲1997例axSpA中486例(24.3%)为nr-axSpA。
  • 亚洲nr-axSpA与非亚洲nr-axSpA相比:男性75.9% vs 47.1%,起病年龄22.8 vs 27.8岁,诊断年龄27.2 vs 34.5岁,诊断延迟1.9 vs 2.9年。
  • 亚洲nr-axSpA与非亚洲nr-axSpA相比:HLA-B27阳性率90.6% vs 61.9%,外周SpA表现53.6% vs 66.3%,关节外表现和共病率相似。
  • 亚洲nr-axSpA疾病活动度、功能受损和MRI骶髂关节炎更轻,NSAID应答率更高,MTX和bDMARD使用更少。
  • 亚洲内部r-axSpA较nr-axSpA疾病活动度和结构损伤更高,其他特征无差异。

临床怎么用

  • 亚洲axSpA中nr-axSpA占比较低,诊断时需注意其以男性、年轻起病、高HLA-B27阳性率为特征。
  • 亚洲nr-axSpA疾病活动度和MRI骶髂关节炎较轻,应确保MRI资源可及以准确诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To delineate characteristics of non-radiographic axial spondyloarthritis (nr-axSpA) in Asia versus non-Asian regions, and compare radiographic axSpA (r-axSpA) with nr-axSpA within Asia. METHODS: Data were collected from the Assessment of SpondyloArthritis international Society-COMOrbidities in SPondyloArthritis database. Categorising patients by region, we compared clinical characteristics between nr-axSpA from Asia vs elsewhere (Europe, the Americas and Africa). Within Asians, we additionally compared patient characteristics of those with nr-axSpA versus r-axSpA. RESULTS: Among 3984 SpA cases, 1094 were from Asian countries. Of 780 axSpA patients in Asia, 112 (14.4%) had nr-axSpA, less than in non-Asian countries (486/1997, 24.3%). Nr-axSpA patients in Asia were predominantly male (75.9% vs 47.1%), younger at onset (22.8 vs 27.8 years) and diagnosis (27.2 vs 34.5 years), and experienced less diagnostic delay (1.9 vs 2.9 years) compared with nr-axSpA in non-Asian countries. Nr-axSpA in Asia exhibited higher human leucocyte antigens-B27 prevalence (90.6% vs 61.9%), fewer peripheral SpA features (53.6% vs 66.3%) and similar extra-articular and comorbid disease rates compared with those with nr-axSpA in non-Asian countries. Disease activity, functional impairment and MRI sacroiliitis were less in nr-axSpA in Asia, with higher rates of non-steroidal anti-inflammatory drug response and less methotrexate and biological disease-modifying antirheumatic drugs use. Within Asia, r-axSpA showed higher disease activity and structural damage compared with nr-axSpA, with no differences in other features. CONCLUSION: Among axSpA, lower frequency of nr-axSpA was observed in Asia. Our results offer an opportunity to better understand clinical characteristics and optimise diagnostic strategies, such as ensuring access and availability of MRI resources for accurate diagnosis of nr-axSpA in Asia.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Kishimoto M, Ono K, Fukui S, et al. Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study. RMD Open. 2021. PMID: 34531305. doi:10.1136/rmdopen-2021-001752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。